Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000950170-24-056947

Principal Accounting Officer sold 236 shares at $7.76 ($1,831)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Tourangeau Greg Principal Accounting Officer 2024-05-07 Sale −236 $7.76 $1,831 11,571 D
Open-market sales · 236 sh · avg $7.76 · $1,831
Loading xslF345X05/ownership.xml…